GLAM
ASPX

Gardner Lewis Asset Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Gardner Lewis Asset Management’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-88,800
Closed -$8.9M – 119
2015
Q1 		$8.9M Buy
+88,800
New +$5.92M 1.87% 13

Gardner Lewis Asset Management's ASPX Position: Q2 2015 in Review

Gardner Lewis Asset Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 88,800 shares — an estimated $8.9M sold.

Gardner Lewis Asset Management first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $8.9M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Gardner Lewis Asset Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 88,800 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $8.9M.
  • Gardner Lewis Asset Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Gardner Lewis Asset Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $8.9M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2015, filed 13 Aug 2015.